Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP230027.RAWT09wvlNYWNAq0EdKTT6ycN3BOaClAl7SYs66izvZ-A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP230027.RAWT09wvlNYWNAq0EdKTT6ycN3BOaClAl7SYs66izvZ-A130_assertion type Assertion NP230027.RAWT09wvlNYWNAq0EdKTT6ycN3BOaClAl7SYs66izvZ-A130_head.
- NP230027.RAWT09wvlNYWNAq0EdKTT6ycN3BOaClAl7SYs66izvZ-A130_assertion description "[We analyzed the influence of angiotensin-converting enzyme (ACE) I/D, angiotensinogen (AGT) M235T and angiotensin-II-type-1 receptor (AT1R) A1166C genetic polymorphisms on the clinical course of focal segmental glomerulosclerosis (FSGS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP230027.RAWT09wvlNYWNAq0EdKTT6ycN3BOaClAl7SYs66izvZ-A130_provenance.
- NP230027.RAWT09wvlNYWNAq0EdKTT6ycN3BOaClAl7SYs66izvZ-A130_assertion evidence source_evidence_literature NP230027.RAWT09wvlNYWNAq0EdKTT6ycN3BOaClAl7SYs66izvZ-A130_provenance.
- NP230027.RAWT09wvlNYWNAq0EdKTT6ycN3BOaClAl7SYs66izvZ-A130_assertion SIO_000772 14610337 NP230027.RAWT09wvlNYWNAq0EdKTT6ycN3BOaClAl7SYs66izvZ-A130_provenance.
- NP230027.RAWT09wvlNYWNAq0EdKTT6ycN3BOaClAl7SYs66izvZ-A130_assertion wasDerivedFrom befree-20150227 NP230027.RAWT09wvlNYWNAq0EdKTT6ycN3BOaClAl7SYs66izvZ-A130_provenance.
- NP230027.RAWT09wvlNYWNAq0EdKTT6ycN3BOaClAl7SYs66izvZ-A130_assertion wasGeneratedBy ECO_0000203 NP230027.RAWT09wvlNYWNAq0EdKTT6ycN3BOaClAl7SYs66izvZ-A130_provenance.